entity

irinotecan

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about irinotecan: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

32Connections
0Hypotheses
0Analyses
1Outgoing
1Incoming
0Experiments

Wiki Pages (5)

Knowledge base pages for this entity

AAIC 2026: Combination Therapy and Multi-Target Approaches in Alzheimer's Disease

event · 2892 words

Combination Therapy Approaches in Neurodegenerative Disease

therapeutic · 2545 words

Section 160: Pharmacogenomics and Personalized Medicine in CBS/PSP

therapeutic · 2046 words

TYDP1 — Tyrosyl-DNA Phosphodiesterase 1

gene · 1793 words

Glial Cells

cell · 614 words

Outgoing (28)

TargetRelationTypeStr
AD-related gene expressionmodulatesphenotype0.60

Incoming (4)

SourceRelationTypeStr
17-DMAGactivatesdrug0.56

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found